CUMYL-PINACA (also known as SGT-24) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 3x selectivity for CB1, having an EC50 of 0.15nM for human CB1 receptors and 0.41nM for human CB2 receptors.[1] In its pure form, it is described as a sticky oil which can cause poisoning through transdermal exposure.[2]

Legal status

Sweden's public health agency suggested classifying CUMYL-PINACA as a hazardous substance, on November 10, 2014.[3]

See also

References

  1. ^ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
  2. ^ Dobaja M, Grenc D, Kozelj G, Brvar M (March 2017). "Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA". Clinical Toxicology. 55 (3): 193–195. doi:10.1080/15563650.2016.1278224. PMID 28084855. S2CID 21304629.
  3. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.